rs2004632

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_015354.3(NUP188):​c.3516-14A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.372 in 1,611,260 control chromosomes in the GnomAD database, including 116,379 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.31 ( 8493 hom., cov: 32)
Exomes 𝑓: 0.38 ( 107886 hom. )

Consequence

NUP188
NM_015354.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.55

Publications

11 publications found
Variant links:
Genes affected
NUP188 (HGNC:17859): (nucleoporin 188) The nuclear pore complex (NPC) is found on the nuclear envelope and forms a gateway that regulates the flow of proteins and RNAs between the cytoplasm and nucleoplasm. The NPC is comprised of approximately 30 distinct proteins collectively known as nucleoporins. Nucleoporins are pore-complex-specific glycoproteins which often have cytoplasmically oriented O-linked N-acetylglucosamine residues and numerous repeats of the pentapeptide sequence XFXFG. However, the nucleoporin protein encoded by this gene does not contain the typical FG repeat sequences found in most vertebrate nucleoporins. This nucleoporin is thought to form part of the scaffold for the central channel of the nuclear pore. [provided by RefSeq, Jan 2013]
NUP188 Gene-Disease associations (from GenCC):
  • sandestig-stefanova syndrome
    Inheritance: AR, Unknown Classification: STRONG, MODERATE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 9-128999158-A-G is Benign according to our data. Variant chr9-128999158-A-G is described in ClinVar as Benign. ClinVar VariationId is 403263.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.392 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NUP188NM_015354.3 linkc.3516-14A>G intron_variant Intron 32 of 43 ENST00000372577.2 NP_056169.1 Q5SRE5-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NUP188ENST00000372577.2 linkc.3516-14A>G intron_variant Intron 32 of 43 1 NM_015354.3 ENSP00000361658.2 Q5SRE5-1
NUP188ENST00000477069.5 linkn.1484-14A>G intron_variant Intron 13 of 18 1

Frequencies

GnomAD3 genomes
AF:
0.308
AC:
46827
AN:
151926
Hom.:
8483
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.120
Gnomad AMI
AF:
0.335
Gnomad AMR
AF:
0.393
Gnomad ASJ
AF:
0.353
Gnomad EAS
AF:
0.172
Gnomad SAS
AF:
0.303
Gnomad FIN
AF:
0.405
Gnomad MID
AF:
0.380
Gnomad NFE
AF:
0.396
Gnomad OTH
AF:
0.336
GnomAD2 exomes
AF:
0.355
AC:
89012
AN:
250688
AF XY:
0.357
show subpopulations
Gnomad AFR exome
AF:
0.108
Gnomad AMR exome
AF:
0.432
Gnomad ASJ exome
AF:
0.347
Gnomad EAS exome
AF:
0.172
Gnomad FIN exome
AF:
0.394
Gnomad NFE exome
AF:
0.399
Gnomad OTH exome
AF:
0.373
GnomAD4 exome
AF:
0.378
AC:
551769
AN:
1459216
Hom.:
107886
Cov.:
32
AF XY:
0.377
AC XY:
273610
AN XY:
725924
show subpopulations
African (AFR)
AF:
0.112
AC:
3742
AN:
33440
American (AMR)
AF:
0.429
AC:
19157
AN:
44670
Ashkenazi Jewish (ASJ)
AF:
0.342
AC:
8919
AN:
26070
East Asian (EAS)
AF:
0.135
AC:
5340
AN:
39668
South Asian (SAS)
AF:
0.317
AC:
27360
AN:
86188
European-Finnish (FIN)
AF:
0.393
AC:
20930
AN:
53232
Middle Eastern (MID)
AF:
0.398
AC:
2276
AN:
5724
European-Non Finnish (NFE)
AF:
0.399
AC:
442638
AN:
1109942
Other (OTH)
AF:
0.355
AC:
21407
AN:
60282
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
15789
31577
47366
63154
78943
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13520
27040
40560
54080
67600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.308
AC:
46851
AN:
152044
Hom.:
8493
Cov.:
32
AF XY:
0.310
AC XY:
23026
AN XY:
74324
show subpopulations
African (AFR)
AF:
0.119
AC:
4958
AN:
41508
American (AMR)
AF:
0.393
AC:
6009
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.353
AC:
1224
AN:
3470
East Asian (EAS)
AF:
0.174
AC:
897
AN:
5166
South Asian (SAS)
AF:
0.304
AC:
1465
AN:
4818
European-Finnish (FIN)
AF:
0.405
AC:
4274
AN:
10560
Middle Eastern (MID)
AF:
0.371
AC:
109
AN:
294
European-Non Finnish (NFE)
AF:
0.396
AC:
26902
AN:
67930
Other (OTH)
AF:
0.336
AC:
708
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1545
3090
4636
6181
7726
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
474
948
1422
1896
2370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.354
Hom.:
2291
Bravo
AF:
0.301
Asia WGS
AF:
0.224
AC:
781
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Sandestig-stefanova syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.70
DANN
Benign
0.58
PhyloP100
-1.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2004632; hg19: chr9-131761437; COSMIC: COSV65361744; COSMIC: COSV65361744; API